M339-0757 Screening compound: 2-[(furan-2-yl)formamido]-N-(3-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)-3-methylbutanamide

M339-0757 Screening compound: 2-[(furan-2-yl)formamido]-N-(3-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)-3-methylbutanamide
M339-0757 Screening compound: 2-[(furan-2-yl)formamido]-N-(3-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)-3-methylbutanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound M339-0757
2-[(furan-2-yl)formamido]-N-(3-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)-3-methylbutanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M339-0757

Molecular Formula

C26H26N4O6 (C26 H26 N4 O6)

Compound Name

2-[(furan-2-yl)formamido]-N-(3-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)-3-methylbutanamide

IUPAC name

2-[(furan-2-yl)formamido]-N-(3-{[5-(4-methoxyphenyl)-134-oxadiazol-2-yl]methoxy}phenyl)-3-methylbutanamide

SMILES

CC(C)C(C(Nc1cc(OCc2nnc(-c(cc3)ccc3OC)o2)ccc1)=O)NC(c1ccco1)=O

InChI

InChI=1S/C26H26N4O6/c1-16(2)23(28-24(31)21-8-5-13-34-21)25(32)27-18-6-4-7-20(14-18)35-15-22-29-30-26(36-22)17-9-11-19(33-3)12-10-17/h4-14,16,23H,15H2,1-3H3,(H,27,32)(H,28,31)/t23-/m0/s1

InChI Key

CXWZBBNPEGORBA-QHCPKHFHSA-N

MDL Number (MFCD)

MFCD27537442

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

490.52

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

3.486

Distribution Coefficient, logD

3.486

Water Solubility, LogSw

-3.67

Polar Surface Area

100.898

Acid Dissociation Constant (pKa)

11.65

Base Dissociation Constant (pKb)

0.80

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

23.10

M339-0757 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

Antimitotic Tubulin Library (17355 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Eccentric PPI Library (11937 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with M339-0757 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound M339-0757?
Check Price and Availability of M339-0757, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of M339-0757 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for M339-0757
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for M339-0757
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of M339-0757 available by request